Potential Therapeutic Applications of MnSODs and SOD‐Mimetics
- 12 December 2017
- journal article
- review article
- Published by Wiley in Chemistry – A European Journal
- Vol. 24 (20) , 5032-5041
Abstract
Natural as well as synthetic antioxidants are constantly being investigated for their efficiency in combatting the effects of oxidative stress, which appears to be the responsible cause of several diseases, including cancer, central nervous system disorders, ischaemia‐reperfusion disorders, cardiovascular conditions, and diabetes. Superoxide dismutases (SODs) constitute the ubiquitous antioxidant defences against oxidative stress that underlies numerous pathological conditions. Therefore, the development of therapeutics aimed at either delivering MnSOD more effectively to target tissues in the body in the form of MnSOD gene therapy, or the synthesis of molecules that mimic the activity of superoxide dismutase is constantly being explored. Classes that have been developed as SOD mimetics include the Mn‐metalloporphyrins, Mn‐cyclic polyamines, Mn‐salen complexes, MnPLED derivatives as well as the nitroxides. Thus far, SOD mimetics have shown remarkable efficacy in several animal models suffering from oxidative stress injuries. A promising approach for the future of SOD and SOD mimic therapeutics appears to involve combination treatment of the antioxidants with radiotherapy or chemotherapy.Keywords
This publication has 110 references indexed in Scilit:
- Late administration of Mn porphyrin-based SOD mimic enhances diabetic complicationsRedox Biology, 2013
- A new SOD mimic, Mn(III) ortho N-butoxyethylpyridylporphyrin, combines superb potency and lipophilicity with low toxicityFree Radical Biology and Medicine, 2012
- Manganese superoxide dismutase, MnSOD and its mimicsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2012
- Manganese Porphyrin, MnTE-2-PyP5+, Acts as a Pro-Oxidant to Potentiate Glucocorticoid-Induced Apoptosis in Lymphoma CellsFree Radical Biology and Medicine, 2012
- Modulation of in utero total body irradiation induced newborn mouse growth retardation by maternal manganese superoxide dismutase-plasmid liposome (MnSOD-PL) gene therapyGene Therapy, 2011
- Extracellular Superoxide Dismutase Is a Growth Regulatory Mediator of Tissue Injury RecoveryMolecular Therapy, 2009
- Manganese superoxide dismutase gene dosage affects chromosomal instability and tumor onset in a mouse model of T cell lymphomaFree Radical Biology and Medicine, 2008
- Comparison of two Mn porphyrin-based mimics of superoxide dismutase in pulmonary radioprotectionFree Radical Biology and Medicine, 2008
- An SOD mimic protects NADP+-dependent isocitrate dehydrogenase against oxidative inactivationFree Radical Research, 2008
- Sod mimetics are coming of ageNature Reviews Drug Discovery, 2002